DNMT1 and non-human animal disease: While most studies were mainly conducted in vitro, further investigations, including in vivo experiments and animal disease models, would be needed to explore the clinical potential in disease treatment and regenerative medicine such as HDACis and DNMT inhibitors related to epigenetic modifications.